Genespark Molecular Label
Genespark is a fast fluorescent molecular labelling technology with unlimited multiplex scalability.
The precursor to the Genespark technology was developed at Robert Gordon University by the team led by Dr. Patricia Pollard and is now being used as a replacement for florescent dyes in document security. The multidisciplinary group brings together expertise in forensic science, microbiology, biochemistry, molecular biology and optical instrumentation. Work began on this project in 2004 and has received funding under the Proof of Concept Program from Scottish Enterprise.
Molecular labels are commonly used for a wide range of human diagnostic purposes ranging from DNA microarrays through to Point of Care antibody tests.
In addition to being a licensing and collaborative opportunity we are in the process of identifying a suitably qualified CEO to lead the Genespark technology to the next level.Key Benefits
- Genespark has an unlimited number of narrow spectra fluorescent emissions, allowing a large number of distinct labels in a single multiplex assay.
- The fast processing and detection time moves diagnostic testing closer to the point of care avoiding delays and saving lives.
- The multiplex capability is scalable having no influence on processing time.
- Each Genespark has a modifiable emission intensity providing different decay times which adds to the target identification profile.
- Genesparks sensitivity means that there is no need for target amplification (PCR)
Applications
- Molecular Diagnostics
- Infections Disease
- Agricultural
- Environmental
- Defence and Forensics
- Research
- Pharmacogenetics
IP Status
Patent Pending
If you would like further information about
this opportunity please fill out the form below. Your enquiry will
be passed on to the relevant University who will respond to you directly.
